Inreda Diabetic – Amsterdam Academic Ventures

Our portfolio

Inreda Diabetic

Developing a bi-hormonal artificial pancreas, Inreda Diabetic offers a closed-loop system for diabetes management. Their device automates insulin and glucagon administration, drastically reducing the burden on patients compared to classic single-hormone pumps. Inreda Diabetic’s technology aims to improve blood glucose control and quality of life for diabetes patients.

Industry: Diabetes, Medical Technology

Want to get in contact about Inreda Diabetic?

We’re happy to connect. Reach out to our investment manager working with the team to learn more or explore potential opportunities.

Marc Roelofs

Life Science & Health

Our portfolio

Check out similar ventures

Cellagenics

Scaling up therapeutic antibody production with STEP® technology.

Enhancing patient care with AI-driven radiology solutions for clinical practice.

Developing advanced machine learning and deep learning technologies, Scyfer specializes in applying these solutions across various industries, including industry, media, and healthcare.

Developing adaptive online learning systems.

Cellagenics

Scaling up therapeutic antibody production with STEP® technology.

Enhancing patient care with AI-driven radiology solutions for clinical practice.

Developing advanced machine learning and deep learning technologies, Scyfer specializes in applying these solutions across various industries, including industry, media, and healthcare.

Developing adaptive online learning systems.

Our portfolio

Want to get in contact about Inreda Diabetic?

Marc Roelofs

Our portfolio

Holdings of our founding institutes

Contact